Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: A randomised clinical trial

British Journal of Ophthalmology

Volumn 93, Issue 8, 2009, Pages 1005-1015

  Christensen, U C ^a,b   Kroyer K ^a   Sander, B ^a   Larsen, M ^a   Henning, V ^a   Villumsen, J ^a   La Cour, M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; TRYPAN BLUE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; OCULAR FIBROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA MACULA HOLE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

AGED; COLORING AGENTS; EPIRETINAL MEMBRANE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETINAL PERFORATIONS; TREATMENT OUTCOME; TRYPAN BLUE; VISUAL ACUITY; VITRECTOMY;

EID: 68049084470     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.151266     Document Type: Article

References (69)

1. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991;109:654-659
2. Couvillion SS, Smiddy WE, Flynn HW Jr, et al. Outcomes of surgery for idiopathic macular hole: a case-control study comparing silicone oil with gas tamponade. Ophthalmic Surg Lasers Imaging 2005;36:365-371
3. Lai JC, Stinnett SS, McCuen BW. Comparison of silicone oil versus gas tamponade in the treatment of idiopathic full-thickness macular hole. Ophthalmology 2003;110:1170-1174
4. Goldbaum MH, McCuen BW, Hanneken AM, et al. Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology 1998;105:2140-2147
5. Karia N, Laidlaw A, West J, et al. Macular hole surgery using silicone oil tamponade. Br J Ophthalmol 2001;85:1320-1323 (Pubitemid 33016112)
6. Kumar V, Banerjee S, Loo AV, et al. Macular hole surgery with silicone oil. Eye 2002;16:121-125 (Pubitemid 34537686)
7. Park DW, Sipperley JO, Sneed SR, et al. Macular hole surgery with internal-limiting membrane peeling and intravitreous air. Ophthalmology 1999;106:1392-1397
8. Hasler PW, Prunte C. Early foveal recovery after macular hole surgery. Br J Ophthalmol 2008;92:645-649 (Pubitemid 351684174)
9. Krohn J. Duration of face-down positioning after macular hole surgery: a comparison between 1 week and 3 days. Acta Ophthalmol Scand 2005;83:289-292 (Pubitemid 40872499)
10. Simcock PR, Scalia S. Phacovitrectomy without prone posture for full thickness macular holes. Br J Ophthalmol 2001;85:1316-1319 (Pubitemid 33016111)
11. Tornambe PE, Poliner LS, Grote K. Macular hole surgery without face-down positioning. A pilot study. Retina 1997;17:179-185
12. Tranos PG, Peter NM, Nath R, et al. Macular hole surgery without prone positioning. Eye 2007;21:802-806 (Pubitemid 46909185)
13. Smiddy WE, Glaser BM, Thompson JT, et al. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Preliminary anatomic results of a multicenter prospective randomized study. Retina 1993;13:296-301.
14. Thompson JT, Smiddy WE, Williams GA, et al. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 1998;105:700-706
15. Blumenkranz MS, Ohana E, Shaikh S, et al. Adjuvant methods in macular hole surgery: intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange. Ophthalmic Surg Lasers 2001;32:198-207. (Pubitemid 32428693)
16. Paques M, Chastang C, Mathis A, et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology 1999;106:932-938 (Pubitemid 30191550)
17. Ezra E, Gregor ZJ. Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group Report no. 1. Arch Ophthalmol 2004;122:224-236 (Pubitemid 38176490)
18. Al-Abdulla NA, Thompson JT, Sjaarda RN. Results of macular hole surgery with and without epiretinal dissection or internal limiting membrane removal. Ophthalmology 2004;111:142-149 (Pubitemid 38032222)
19. Brooks HL Jr. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 2000;107:1939-1948
20. Eckardt C, Eckardt U, Groos S, et al. Removal of the internal limiting membrane in macular holes. Clinical and morphological findings. Ophthalmologe 1997;94:545-551 (Pubitemid 27396050)
21. Kwok AK, Lai TY, Wong VW. Idiopathic macular hole surgery in Chinese patients: a randomised study to compare indocyanine green-assisted internal limiting membrane peeling with no internal limiting membrane peeling. Hong Kong Med J 2005;11:259-266
22. Margherio RR, Margherio AR, Williams GA, et al. Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes. Arch Ophthalmol 2000;118:495-498
23. Mester V, Kuhn F. Internal limiting membrane removal in the management of fullthickness macular holes. Am J Ophthalmol 2000;129:769-777 (Pubitemid 30604157)
24. Smiddy WE, Feuer W, Cordahi G. Internal limiting membrane peeling in macular hole surgery. Ophthalmology 2001;108:1471-1476 (Pubitemid 32709039)
25. Tognetto D, Grandin R, Sanguinetti G, et al. Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology 2006;113:1401-1410 (Pubitemid 44108180)
26. Yooh HS, Brooks HL Jr, Capone A Jr, et al. Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 1996;122:67-75. (Pubitemid 26230895)
27. Schaal KB, Bartz-Schmidt KU, Dithmar S. Current strategies for macular hole surgery in Germany, Austria and Switzerland. Ophthalmologe 2006;103:922-926 (Pubitemid 44769914)
28. Burk SE, Da Mata AP, Snyder ME, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000;107:2010-2014 (Pubitemid 30823182)
29. Kadonosono K, Itoh N, Uchio E, et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-1118 (Pubitemid 30643346)
30. Haritoglou C, Gass CA, Schaumberger M, et al. Macular changes after peeling of the internal limiting membrane in macular hole surgery. Am J Ophthalmol 2001;132:363-368 (Pubitemid 32768605)
31. Haritoglou C, Ehrt O, Gass CA, et al. Paracentral scotomata: a new finding after vitrectomy for idiopathic macular hole. Br J Ophthalmol 2001;85:231-233 (Pubitemid 32146769)
32. Kanda S, Uemura A, Yamashita T, et al. Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 2004;122:1447-1451 (Pubitemid 39336543)
33. Tsuiki E, Fujikawa A, Miyamura N, et al. Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2007;143:704-705 (Pubitemid 46452496)
34. Poliner LS, Tornambe PE. Retinal pigment epitheliopathy after macular hole surgery. Ophthalmology 1992;99:1671-1677
35. Tadayoni R, Paques M, Massin P, et al. Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology 2001;108:2279-2283 (Pubitemid 33096943)
36. Ito Y, Terasaki H, Takahashi A, et al. Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular holes. Ophthalmology 2005;112:1415-1420 (Pubitemid 41074633)
37. Karacorlu M, Karacorlu S, Ozdemir H. Iatrogenic punctate chorioretinopathy after internal limiting membrane peeling. Am J Ophthalmol 2003;135:178-182 (Pubitemid 36151794)
38. Enaida H, Sakamoto T, Hisatomi T, et al. Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol 2002;240:209-213 (Pubitemid 36097057)
39. Engelbrecht NE, Freeman J, Sternberg P Jr, et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2002;133:89-94. (Pubitemid 34076506)
40. Gandorfer A, Haritoglou C, Gandorfer A, et al. Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 2003;44:316-323 (Pubitemid 36134291)
41. Goldstein M, Zemel E, Loewenstein A, et al. Retinal toxicity of indocyanine green in albino rabbits. Invest Ophthalmol Vis Sci 2006;47:2100-2107 (Pubitemid 46768294)
42. Yip HK, Lai TY, So KF, et al. Retinal ganglion cells toxicity caused by photosensitising effects of intravitreal indocyanine green with illumination in rat eyes. Br J Ophthalmol 2006;90:99-102.
43. Ho JD, Tsai RJ, Chen SN, et al. Cytotoxicity of indocyanine green on retinal pigment epithelium: implications for macular hole surgery. Arch Ophthalmol 2003;121:1423-1429 (Pubitemid 37243743)
44. Iriyama A, Uchida S, Yanagi Y, et al. Effects of indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis Sci 2004;45:943-947 (Pubitemid 38868396)
45. Jackson TL, Hillenkamp J, Knight BC, et al. Safety testing of indocyanine green and Trypan Blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004;45:2778-2785 (Pubitemid 38998877)
46. Sippy BD, Engelbrecht NE, Hubbard GB, et al. Indocyanine green effect on cultured human retinal pigment epithelial cells: implication for macular hole surgery. Am J Ophthalmol 2001;132:433-435 (Pubitemid 32768628)
47. Ando F, Sasano K, Ohba N, et al. Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 2004;137:609-614 (Pubitemid 38446672)
48. Ferencz M, Somfai GM, Farkas A, et al. Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery. Am J Ophthalmol 2006;142:765-770 (Pubitemid 44584133)
49. Horio N, Horiguchi M. Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol 2004;122:992-996 (Pubitemid 39037963)
50. Kwok AK, Lai TY, Li WW, et al. Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study. Am J Ophthalmol 2004;138:194-199 (Pubitemid 39037421)
51. Thompson JT, Glaser BM, Sjaarda RN, et al. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 1995;119:48-54.
52. Kiilgaard JF, Nissen MH, la CM. An isotonic preparation of 1 mg/ml indocyanine green is not toxic to hyperconfluent ARPE19 cells, even after prolonged exposure. Acta Ophthalmol Scand 2006;84:42-46
53. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-1194 (Pubitemid 32378696)
54. Gass JD. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 1988;106:629-639
55. Gass JD. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995;119:752-759
56. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
57. Beutel J, Dahmen G, Ziegler A, et al. Internal limiting membrane peeling with indocyanine green or Trypan Blue in macular hole surgery: a randomized trial. Arch Ophthalmol 2007;125:326-332 (Pubitemid 46425559)
58. Blain P, Paques M, Massin P, et al. Epiretinal membranes surrounding idiopathic macular holes. Retina 1998;18:316-321 (Pubitemid 30387101)
59. Cheng L, Freeman WR, Ozerdem U, et al. Prevalence, correlates, and natural history of epiretinal membranes surrounding idiopathic macular holes. Virectomy for Macular Hole Study Group. Ophthalmology 2000;107:853-859 (Pubitemid 30727992)
60. Leonard RE, Smiddy WE, Flynn HW Jr, et al. Long-term visual outcomes in patients with successful macular hole surgery. Ophthalmology 1997;104:1648-1652 (Pubitemid 28053466)
61. Narayanan R, Kenney MC, Kamjoo S, et al. Trypan Blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci 2005;46:304-309 (Pubitemid 40041212)
62. Kodjikian L, Richter T, Halberstadt M, et al. Toxic effects of indocyanine green, infracyanine green, and Trypan Blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol 2005;243:917-925 (Pubitemid 41386717)
63. Rezai KA, Farrokh-Siar L, Gasyna EM, et al. Trypan Blue induces apoptosis in human retinal pigment epithelial cells. Am J Ophthalmol 2004;138:492-495 (Pubitemid 39208587)
64. Gass CA, Haritoglou C, Messmer EM, et al. Peripheral visual field defects after macular hole surgery: a complication with decreasing incidence. Br J Ophthalmol 2001;85:549-551 (Pubitemid 32397828)
65. Biro Z, Kovacs B. Results of cataract surgery in previously vitrectomized eyes. J Cataract Refract Surg 2002;28:1003-1006 (Pubitemid 34586990)
66. Szijarto Z, Haszonits B, Biro Z, et al. Phacoemulsification on previously vitrectomized eyes: results of a 10-year-period. Eur J Ophthalmol 2007;17:601-604 (Pubitemid 47605770)
67. Bhatnagar P, Kaiser PK, Smith SD, et al. Reopening of previously closed macular holes after cataract extraction. Am J Ophthalmol 2007;144:252-259 (Pubitemid 47094740)
68. Lahey JM, Francis RR, Fong DS, et al. Combining phacoemulsification with vitrectomy for treatment of macular holes. Br J Ophthalmol 2002;86:876-878 (Pubitemid 34827967)
69. Tornambe PE, Poliner LS, Grote K. Macular hole surgery without face-down positioning. A pilot study. Retina 1997;17:179-185